MEI Pharma Don Launch $100M Litecoin Treasury, Shares Jump 50%
MEI Pharma, one Nasdaq-listed biotech company, don launch one $100 million Litecoin treasury plan to diversify how dem dey arrange their assets. Di plan na led by Titan Partners and GSR, e get backing from Litecoin Foundation, wey also take some strategic equity inside MEI Pharma. Litecoin creator Charlie Lee join MEI Pharma board to push for institutional Litecoin adoption, talking about di low fees, quick settlement, and di confirmed ways wey people dey use Litecoin for payment. Di announcement make MEI Pharma shares jump over 50% when market open and na one of di largest corporate Litecoin treasury plans so far. This move come after Thumzup Media $250 million crypto asset plan, wey show say more institutions dey interested for Litecoin and other digital currencies. Traders go dey watch how di Litecoin treasury plan go affect LTC demand, market liquidity, and MEI Pharma stock wahala.
Bullish
Dis news na beta for LTC becos $100 million wey dem put for company treasury show say institution dem get correct confidence and e dey drive demand. Charlie Lee appointment for board and Litecoin Foundation equity stake dey add credibiliti, while di jump for share price dey highlight di market enthusiasm. Big company adoption often dey lead to more network usage and less sell pressure, e dey support short-term price spike and long-term value growth.